Skip Navigation

National Institutes of Health

Location

National Institutes of Health
Clinical Center, Building 10
9000 Rockville Pike
Bethesda, MD 20892
Direct phone: (301) 496-4000

Total transplants by cell source

From January 1, 2017 to December 31st, 2018
  • Marrow: 40
  • PBSC: 80
  • Cord Blood: 4
  • Autologous (PBSC or Marrow): 0
Performs adult; pediatric transplants

Overview

This NIH Clinical Center program supports innovative transplant approaches conducted by three NIH Institutes (NCI, NIAID, and NHLBI). To undergo a transplant, patients must be enrolled in an active clinical trial at one of these institutes.

This center has been performing allogeneic transplants since 1992 and has been an NMDP/Be The Match transplant center since March 2007.

Attending physicians

Adult - Inhye Ahn, Daisuke Araki, George Aue, Charles Bolan, Jennifer Brudno, Richard Childs, Stefan Cordes, Lea Cunningham, Dimana Dimitrova, Courtney Fitzhugh, Ronald Gress, Dennis Hickstein, Noa Hotzman, Matthew Hsieh, Christopher Kanakry, Jennifer Kanakry, Elizabeth Kang, Andre LaRochelle, Harry Malech, Rosa Nadal Rios, Steven Pavletic, Chris Pleyer, Rosa Nadal Rios, Kate Stringaris, Clare Sun, John Tisdale

Pediatric - Richard Childs, Dimana Dimitrova, Courtney Fitzhugh, Ronald Gress, Jennifer Kanakry, Nirali Shah, Haneen Shalabi

Transplants performed

Marrow/PBSC and single cord

Cord blood transplants performed on

Adult and pediatric

Other programs and services

Transplants are provided free of charge to patients who are enrolled on a clinical trial at NIH.

About the center

Overview

This NIH Clinical Center program supports innovative transplant approaches conducted by three NIH Institutes (NCI, NIAID, and NHLBI). To undergo a transplant, patients must be enrolled in an active clinical trial at one of these institutes.

This center has been performing allogeneic transplants since 1992 and has been an NMDP/Be The Match transplant center since March 2007.

Attending physicians

Adult - Inhye Ahn, Daisuke Araki, George Aue, Charles Bolan, Jennifer Brudno, Richard Childs, Stefan Cordes, Lea Cunningham, Dimana Dimitrova, Courtney Fitzhugh, Ronald Gress, Dennis Hickstein, Noa Hotzman, Matthew Hsieh, Christopher Kanakry, Jennifer Kanakry, Elizabeth Kang, Andre LaRochelle, Harry Malech, Rosa Nadal Rios, Steven Pavletic, Chris Pleyer, Rosa Nadal Rios, Kate Stringaris, Clare Sun, John Tisdale

Pediatric - Richard Childs, Dimana Dimitrova, Courtney Fitzhugh, Ronald Gress, Jennifer Kanakry, Nirali Shah, Haneen Shalabi

Transplants performed

Marrow/PBSC and single cord

Cord blood transplants performed on

Adult and pediatric

Other programs and services

Transplants are provided free of charge to patients who are enrolled on a clinical trial at NIH.

Overall center survival


Patient survival information for this center

National Heart Lung & Blood Institute

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 79 patients.

The actual 1-year survival of these patients is 84.6%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 70.9% and 87.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

National Institutes of Allergy & Infectious Disease

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 8 patients.

The actual 1-year survival of these patients is 75.0%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 39.5% and 99.0%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

National Institutes of Health

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 1 patient.

The actual 1-year survival of this patient is 100.0%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 4.3% and 100.0%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

NIH - Experimental Transplantation and Immunology Branch (Related Donor Program)

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 66 patients.

The actual 1-year survival of these patients is 81.8%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.8% and 85.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

NIH - NCI Matched Unrelated Donor Program

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 70 patients.

The actual 1-year survival of these patients is 84.2%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 66.3% and 85.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Number of adult transplants

Total adult transplants


103

Transplants reported (From January 1, 2017 to December 31st, 2018 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 14 45 0 59
Unrelated donor 14 27 3 44
Total allogeneic 28 72 3 103
Autologous
Both marrow & PBSC
0
-- 0
Total combined
100 3 103

Number of pediatric transplants

Total pediatric transplants


21

Transplants reported (From January 1, 2017 to December 31st, 2018 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 9 4 0 13
Unrelated donor 3 4 1 8
Total allogeneic 12 8 1 21
Autologous
Both marrow & PBSC
0
-- 0
Total combined
20 1 21

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2017 to December 31st, 2018 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 15 47 9 1 72
Unrelated 9 30 11 2 52
Autologous 0 0 0 0 0
Total 24 77 20 3 124

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

If you have transplant-related questions, please call the transplant center's direct phone number.

If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program

This center has separate survivorship programs for adult and pediatric patients.
Please select the program you are interested in.